SEARCH RESULTS for assignor:"LOKHORST, HENK"

Showing 1 to 3 of 3 results

Last Update Patent(s) Assignor(s) Orig. Assignee(s) Assignee(s) Reel/Frame
30-Apr-2018

(X0) 15191808: Immune Modulation and Treatment of Solid Tumors with Antibodies that Specifically Bind CD38

(A1) 20160376373: Immune Modulation and Treatment of Solid Tumors with Antibodies that Specifically Bind CD38

AHMADI, TAHAMTAN

SASSER, AMY

CASNEUF, TINEKE

LOKHORST, HENK

MUTIS, TUNA

VAN DE DONK, NIELS

JANSSEN BIOTECH, INC.

45662/229

28-Mar-2018

(X0) 15340214: Immune Modulation and Treatment of Solid Tumors with Antibodies that Specifically Bind CD38

(A1) 20170044265: Immune Modulation and Treatment of Solid Tumors with Antibodies that Specifically Bind CD38

AHMADI, TAHAMTAN

CASNEUF, TINEKE

LOKHORST, HENK

MUTIS, TUNA

SASSER, AMY

VAN DE DONK, NIELS

JANSSEN BIOTECH, INC.

45356/222

12-Feb-2018

(X0) 15189577: Combination therapies for heme malignancies with Anti-CD38 antibodies and survivin inhibitors

(A1) 20160367663: Combination therapies for heme malignancies with Anti-CD38 antibodies and survivin inhibitors

DOSHI, PARUL

LOKHORST, HENK

MUTIS, TUNA

JANSSEN BIOTECH, INC.

44878/829